Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Kinnevik announces support for proposed Teladoc Health and Livongo merger » 07:15
08/05/20
08/05
07:15
08/05/20
07:15
LVGO

Livongo Health

$144.48 /

+7.88 (+5.77%)

, TDOC

Teladoc

$249.11 /

+11.77 (+4.96%)

Kinnevik AB, which is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

07/29/20 RBC Capital
Livongo Health ending re-seller relationship with CVS Health, says RBC Capital
07/15/20
Fly Intel: Top five analyst initiations
07/14/20 Credit Suisse
Livongo Health initiated with an Outperform at Credit Suisse
07/14/20 KeyBanc
UnitedHealth competition won't impact Livongo near term, says KeyBanc
TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

07/30/20 Wells Fargo
Teladoc price target raised to $175 from $135 at Wells Fargo
07/30/20 Canaccord
Teladoc price target raised to $255 from $195 at Canaccord
07/30/20 JPMorgan
Teladoc price target raised to $266 from $240 at JPMorgan
07/30/20 Credit Suisse
Teladoc price target raised to $225 from $165 at Credit Suisse
LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

  • 12
    Dec
LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

Hot Stocks
Teladoc, Livongo Health to merge in cash and stock transaction » 06:11
08/05/20
08/05
06:11
08/05/20
06:11
TDOC

Teladoc

$249.11 /

+11.77 (+4.96%)

, LVGO

Livongo Health

$144.48 /

+7.88 (+5.77%)

Teladoc Health (TDOC) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

07/30/20 Wells Fargo
Teladoc price target raised to $175 from $135 at Wells Fargo
07/30/20 Canaccord
Teladoc price target raised to $255 from $195 at Canaccord
07/30/20 JPMorgan
Teladoc price target raised to $266 from $240 at JPMorgan
07/30/20 Credit Suisse
Teladoc price target raised to $225 from $165 at Credit Suisse
LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

07/29/20 RBC Capital
Livongo Health ending re-seller relationship with CVS Health, says RBC Capital
07/15/20
Fly Intel: Top five analyst initiations
07/14/20 Credit Suisse
Livongo Health initiated with an Outperform at Credit Suisse
07/14/20 KeyBanc
UnitedHealth competition won't impact Livongo near term, says KeyBanc
TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

  • 12
    Dec
TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

Hot Stocks
Teladoc, Livongo Health to merge in cash and stock transaction  06:09
08/05/20
08/05
06:09
08/05/20
06:09
TDOC

Teladoc

$249.11 /

+11.77 (+4.96%)

, LVGO

Livongo Health

$144.48 /

+7.88 (+5.77%)

 
ShowHide Related Items >><<
TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

07/30/20 Wells Fargo
Teladoc price target raised to $175 from $135 at Wells Fargo
07/30/20 Canaccord
Teladoc price target raised to $255 from $195 at Canaccord
07/30/20 JPMorgan
Teladoc price target raised to $266 from $240 at JPMorgan
07/30/20 Credit Suisse
Teladoc price target raised to $225 from $165 at Credit Suisse
LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

07/29/20 RBC Capital
Livongo Health ending re-seller relationship with CVS Health, says RBC Capital
07/15/20
Fly Intel: Top five analyst initiations
07/14/20 Credit Suisse
Livongo Health initiated with an Outperform at Credit Suisse
07/14/20 KeyBanc
UnitedHealth competition won't impact Livongo near term, says KeyBanc
TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

  • 12
    Dec
TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

TDOC Teladoc
$249.11 /

+11.77 (+4.96%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

Hot Stocks
Livongo Health reports 1,328 clients as of June 30, up 75% y/y » 06:03
08/05/20
08/05
06:03
08/05/20
06:03
LVGO

Livongo Health

$144.48 /

+7.88 (+5.77%)

Livongo for Diabetes…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

07/29/20 RBC Capital
Livongo Health ending re-seller relationship with CVS Health, says RBC Capital
07/15/20
Fly Intel: Top five analyst initiations
07/14/20 Credit Suisse
Livongo Health initiated with an Outperform at Credit Suisse
07/14/20 KeyBanc
UnitedHealth competition won't impact Livongo near term, says KeyBanc
LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

  • 12
    Dec
LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

Earnings
Livongo Health reports Q2 adjusted EPS 11c, consensus 1c » 06:02
08/05/20
08/05
06:02
08/05/20
06:02
LVGO

Livongo Health

$144.48 /

+7.88 (+5.77%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

07/29/20 RBC Capital
Livongo Health ending re-seller relationship with CVS Health, says RBC Capital
07/15/20
Fly Intel: Top five analyst initiations
07/14/20 Credit Suisse
Livongo Health initiated with an Outperform at Credit Suisse
07/14/20 KeyBanc
UnitedHealth competition won't impact Livongo near term, says KeyBanc
LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

  • 12
    Dec
LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

LVGO Livongo Health
$144.48 /

+7.88 (+5.77%)

Downgrade
AssetMark Financial downgraded to Neutral from Overweight at JPMorgan » 04:46
08/05/20
08/05
04:46
08/05/20
04:46
AMK

AssetMark Financial

$27.20 /

-0.49 (-1.77%)

JPMorgan analyst Kenneth…

JPMorgan analyst Kenneth Worthington downgraded AssetMark Financial to Neutral from Overweight with a $27 price target.

ShowHide Related Items >><<
AMK AssetMark Financial
$27.20 /

-0.49 (-1.77%)

AMK AssetMark Financial
$27.20 /

-0.49 (-1.77%)

07/15/20 Raymond James
AssetMark Financial price target raised to $31 from $27 at Raymond James
04/14/20 Raymond James
AssetMark Financial price target lowered to $26 from $29 at Raymond James
03/13/20 Raymond James
AssetMark Financial price target lowered to $29 from $33 at Raymond James
01/16/20 Raymond James
AssetMark Financial price target raised to $34 from $32 at Raymond James
AMK AssetMark Financial
$27.20 /

-0.49 (-1.77%)

AMK AssetMark Financial
$27.20 /

-0.49 (-1.77%)

Yesterday
Earnings
Owl Rock reports Q2 EPS 79c, consensus 37c » 18:30
08/04/20
08/04
18:30
08/04/20
18:30
ORCC

Owl Rock

$12.20 /

+0.155 (+1.29%)

Reported net asset value…

Reported net asset value per share was $14.52 at June 30 as compared to $14.09 at March 31. Craig W. Packer, CEO commented, "While this quarter was marked by unprecedented economic disruption, we believe our results highlight the strength of our team, credit quality and balance sheet. Our strategy of building a well-diversified, senior-oriented portfolio and conservative balance sheet has served our investors well and should allow us to deliver attractive returns in the future. As a result, we are well positioned to both support our existing borrowers where necessary and selectively pursue new opportunities, where we believe our scale, expertise and focus make us a partner of choice."

ShowHide Related Items >><<
ORCC Owl Rock
$12.20 /

+0.155 (+1.29%)

ORCC Owl Rock
$12.20 /

+0.155 (+1.29%)

04/16/20 Raymond James
Owl Rock upgraded to Outperform at Raymond James on valuation
04/16/20 Raymond James
Owl Rock upgraded to Outperform from Market Perform at Raymond James
04/13/20 BofA
Owl Rock upgraded to Buy from Neutral at BofA
04/13/20 BofA
Owl Rock upgraded to Buy from Neutral at BofA
ORCC Owl Rock
$12.20 /

+0.155 (+1.29%)

Earnings
AssetMark Financial reports Q2 EPS 21c, consensus 22c » 17:04
08/04/20
08/04
17:04
08/04/20
17:04
AMK

AssetMark Financial

$27.20 /

-0.49 (-1.77%)

Reports Q2 revenue $99M,…

Reports Q2 revenue $99M, consensus $66.4M. "AssetMark continues to grow. In the second quarter, we added 178 new producing advisors and had net flows of $907 million. Platform assets ended the second quarter at $63.2 billion, an all-time high," said Charles Goldman, President and CEO. "This growth, while muted relative to the same period last year, demonstrates the resilience of AssetMark's model as we navigate a very challenging environment." Goldman concluded, "The industry landscape continues to change and during the pandemic, we see that change accelerating. Investors are looking for more from advisors. Advisors who adopt a fiduciary model, focus on financial planning and use technology to scale their practices, are best positioned to win. AssetMark's platform delivers capacity and capabilities for advisors so they can focus on their clients, scale their practices and grow faster."

ShowHide Related Items >><<
AMK AssetMark Financial
$27.20 /

-0.49 (-1.77%)

AMK AssetMark Financial
$27.20 /

-0.49 (-1.77%)

07/15/20 Raymond James
AssetMark Financial price target raised to $31 from $27 at Raymond James
04/14/20 Raymond James
AssetMark Financial price target lowered to $26 from $29 at Raymond James
03/13/20 Raymond James
AssetMark Financial price target lowered to $29 from $33 at Raymond James
01/16/20 Raymond James
AssetMark Financial price target raised to $34 from $32 at Raymond James
AMK AssetMark Financial
$27.20 /

-0.49 (-1.77%)

AMK AssetMark Financial
$27.20 /

-0.49 (-1.77%)

On The Fly
Game On: EA, Take-Two report net bookings hike amid pandemic » 12:27
08/04/20
08/04
12:27
08/04/20
12:27
SNE

Sony

$83.01 /

+1.72 (+2.12%)

, SGAMY

Sega Sammy Holdings

$0.00 /

+ (+0.00%)

, EA

Electronic Arts

$145.01 /

+2.73 (+1.92%)

, TTWO

Take-Two

$174.65 /

+6.64 (+3.95%)

, NTDOY

Nintendo

$0.00 /

+ (+0.00%)

, ATVI

Activision Blizzard

$85.18 /

+0.415 (+0.49%)

, UBSFY

Ubisoft

$0.00 /

+ (+0.00%)

, MSFT

Microsoft

$211.25 /

-5.35 (-2.47%)

, GOOG

Alphabet

$1,461.06 /

-11.9 (-0.81%)

, GOOGL

Alphabet Class A

$1,468.42 /

-14.36 (-0.97%)

, TCEHY

Tencent

$0.00 /

+ (+0.00%)

, GME

GameStop

$4.58 /

+0.43 (+10.36%)

"Game On" is The Fly's…

Open Full Text

ShowHide Related Items >><<
UBSFY Ubisoft
$0.00 /

+ (+0.00%)

TTWO Take-Two
$174.65 /

+6.64 (+3.95%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

SNE Sony
$83.01 /

+1.72 (+2.12%)

NTDOY Nintendo
$0.00 /

+ (+0.00%)

MSFT Microsoft
$211.25 /

-5.35 (-2.47%)

GOOG Alphabet
$1,461.06 /

-11.9 (-0.81%)

GME GameStop
$4.58 /

+0.43 (+10.36%)

EA Electronic Arts
$145.01 /

+2.73 (+1.92%)

ATVI Activision Blizzard
$85.18 /

+0.415 (+0.49%)

SNE Sony
$83.01 /

+1.72 (+2.12%)

07/30/20
Fly Intel: Top five analyst initiations
07/29/20 Goldman Sachs
Sony resumed with a Conviction Buy at Goldman Sachs
07/16/20 Guggenheim
Best Buy price target raised to $100 from $90 at Guggenheim
07/07/20 Loop Capital
Logitech price target raised to $78 from $58 at Loop Capital
SGAMY Sega Sammy Holdings
$0.00 /

+ (+0.00%)

06/09/20 JPMorgan
Sega Sammy Holdings downgraded to Neutral from Overweight at JPMorgan
EA Electronic Arts
$145.01 /

+2.73 (+1.92%)

07/31/20
Fly Intel: Top five analyst upgrades
07/31/20 JPMorgan
Electronic Arts price target raised to $150 from $127 at JPMorgan
07/31/20 MKM Partners
Electronic Arts price target raised to $160 from $144 at MKM Partners
07/31/20 KeyBanc
Electronic Arts upgraded to Overweight from Sector Weight at KeyBanc
TTWO Take-Two
$174.65 /

+6.64 (+3.95%)

08/04/20
Fly Intel: Top five analyst downgrades
08/04/20 MKM Partners
Take-Two price target raised to $190 from $165 at MKM Partners
08/04/20 Wedbush
Take-Two price target raised to $210 from $170 at Wedbush
08/04/20 Oppenheimer
Take-Two price target raised to $190 from $155 at Oppenheimer
NTDOY Nintendo
$0.00 /

+ (+0.00%)

07/29/20 Goldman Sachs
Nintendo resumed with a Buy at Goldman Sachs
07/16/20 Citi
Nintendo price target raised to 59,000 yen from 47,000 yen at Citi
06/24/20
Fly Intel: Top five analyst downgrades
06/24/20 Wedbush
Nintendo downgraded to Neutral at Wedbush as catalysts may prove 'elusive'
ATVI Activision Blizzard
$85.18 /

+0.415 (+0.49%)

07/30/20 Berenberg
Activision Blizzard price target raised to $88 from $83 at Berenberg
07/23/20 KeyBanc
Activision Blizzard price target raised to $90 from $83 at KeyBanc
07/22/20 Wells Fargo
Activision Blizzard price target raised to $92 from $84 at Wells Fargo
07/21/20 Stifel
Activision Blizzard price target raised to $90 from $81 at Stifel
UBSFY Ubisoft
$0.00 /

+ (+0.00%)

07/23/20 JPMorgan
Ubisoft price target raised to EUR 82 from EUR 79 at JPMorgan
07/17/20 Oddo BHF
Ubisoft downgraded to Neutral from Buy at Oddo BHF
07/13/20 Jefferies
Ubisoft downgraded to Hold from Buy at Jefferies
07/13/20 Societe Generale
Ubisoft downgraded to Hold from Buy at Societe Generale
MSFT Microsoft
$211.25 /

-5.35 (-2.47%)

08/04/20 Wedbush
Wedbush sees 75%-80% chance of Microsoft buying TikTok's U.S. operations
08/04/20 Oppenheimer
TikTok presents 'unique opportunity' for Microsoft, says Oppenheimer
08/03/20 Wedbush
Wedbush sees a TikTok deal as big bet from Microsoft on social media space
07/31/20 Stifel
Citrix disclosure points to $1B commitment, most likely to Azure, says Stifel
GOOG Alphabet
$1,461.06 /

-11.9 (-0.81%)

08/03/20 Goldman Sachs
ADT Inc. price target raised to $17 from $9 at Goldman Sachs
08/03/20 William Blair
Alarm.com downgraded to Market Perform from Outperform at William Blair
08/03/20 Morgan Stanley
ADT Inc. price target raised to $17 from $7 at Morgan Stanley
08/03/20 Credit Suisse
ADT Inc. price target raised to $8.70 from $7 at Credit Suisse
GOOGL Alphabet Class A
$1,468.42 /

-14.36 (-0.97%)

08/03/20 William Blair
Alarm.com downgraded at William Blair on ADT/Google overhang
TCEHY Tencent
$0.00 /

+ (+0.00%)

08/03/20 Morgan Stanley
Sohu.com named a Research Tactical Idea at Morgan Stanley
07/27/20 Barclays
Tencent price target raised to $75 from $63 at Barclays
07/14/20 Citi
Tencent price target raised to HK$649 from HK$541 at Citi
07/08/20 Mizuho
Tencent price target raised to HK$475 from HK$410 at Mizuho
GME GameStop
$4.58 /

+0.43 (+10.36%)

06/11/20 Ascendiant
GameStop price target raised to $4 from $3 at Ascendiant
06/10/20 Baird
GameStop significant challenges remain ahead, says Baird
04/21/20 Baird
GameStop FY20 EPS target cut at Baird
03/27/20 Baird
GameStop trneds to remain weak despite recent increase, says Baird
UBSFY Ubisoft
$0.00 /

+ (+0.00%)

TTWO Take-Two
$174.65 /

+6.64 (+3.95%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

SNE Sony
$83.01 /

+1.72 (+2.12%)

NTDOY Nintendo
$0.00 /

+ (+0.00%)

MSFT Microsoft
$211.25 /

-5.35 (-2.47%)

GOOG Alphabet
$1,461.06 /

-11.9 (-0.81%)

GME GameStop
$4.58 /

+0.43 (+10.36%)

EA Electronic Arts
$145.01 /

+2.73 (+1.92%)

ATVI Activision Blizzard
$85.18 /

+0.415 (+0.49%)

UBSFY Ubisoft
$0.00 /

+ (+0.00%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

SNE Sony
$83.01 /

+1.72 (+2.12%)

NTDOY Nintendo
$0.00 /

+ (+0.00%)

MSFT Microsoft
$211.25 /

-5.35 (-2.47%)

GOOG Alphabet
$1,461.06 /

-11.9 (-0.81%)

GME GameStop
$4.58 /

+0.43 (+10.36%)

EA Electronic Arts
$145.01 /

+2.73 (+1.92%)

ATVI Activision Blizzard
$85.18 /

+0.415 (+0.49%)

TTWO Take-Two
$174.65 /

+6.64 (+3.95%)

TCEHY Tencent
$0.00 /

+ (+0.00%)

SNE Sony
$83.01 /

+1.72 (+2.12%)

MSFT Microsoft
$211.25 /

-5.35 (-2.47%)

GOOG Alphabet
$1,461.06 /

-11.9 (-0.81%)

GME GameStop
$4.58 /

+0.43 (+10.36%)

EA Electronic Arts
$145.01 /

+2.73 (+1.92%)

TTWO Take-Two
$174.65 /

+6.64 (+3.95%)

SNE Sony
$83.01 /

+1.72 (+2.12%)

MSFT Microsoft
$211.25 /

-5.35 (-2.47%)

GME GameStop
$4.58 /

+0.43 (+10.36%)

EA Electronic Arts
$145.01 /

+2.73 (+1.92%)

ATVI Activision Blizzard
$85.18 /

+0.415 (+0.49%)

MSFT Microsoft
$211.25 /

-5.35 (-2.47%)

Hot Stocks
Medipharm Labs appoints Chris Halyk to board of directors Johnson & Johnson » 08:47
08/04/20
08/04
08:47
08/04/20
08:47
MEDIF

Medipharm Labs

$0.00 /

+ (+0.00%)

, JNJ

Johnson & Johnson

$147.39 /

+1.61 (+1.10%)

MediPharm Labs Corp.…

MediPharm Labs Corp. (MEDIF) is pleased to announce the appointment of Chris Halyk, former President of Janssen, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (JNJ), to its Board of Directors, effective immediately. This is the third appointment that the Company's Board has made this year to prepare MediPharm Labs for its next stage of international growth and development.

ShowHide Related Items >><<
MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

JNJ Johnson & Johnson
$147.39 /

+1.61 (+1.10%)

MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

08/07/19 Roth Capital
Medipharm Labs initiated with a Buy at Roth Capital
JNJ Johnson & Johnson
$147.39 /

+1.61 (+1.10%)

07/30/20 BofA
BofA says hard to compare Moderna COVID data to competing preclinical data
07/29/20 Laidlaw
Curis initiated with a Buy at Laidlaw
07/17/20 Goldman Sachs
J&J valuation discount to S&P 500 'too wide,' says Goldman Sachs
07/17/20 Citi
Johnson & Johnson price target raised to $170 from $165 at Citi
MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

JNJ Johnson & Johnson
$147.39 /

+1.61 (+1.10%)

JNJ Johnson & Johnson
$147.39 /

+1.61 (+1.10%)

MEDIF Medipharm Labs
$0.00 /

+ (+0.00%)

JNJ Johnson & Johnson
$147.39 /

+1.61 (+1.10%)

JNJ Johnson & Johnson
$147.39 /

+1.61 (+1.10%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.